title: Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies.
abstract: In alcoholic hepatitis, a severe form of alcohol-induced toxic liver injury, as well as in experimental intoxication of mice with the porphyrinogenic drugs griseofulvin and 3,5-diethoxycarbonyl-1, 4-dihydrocollidine, hepatocytes form cytoplasmic protein aggregates (Mallory bodies; MBs) containing cytokeratins (CKs) and non-CK components. Here we report that mice lacking the CK8 gene and hence CK intermediate filaments in hepatocytes, but still expressing the type I partner, ie, the CK18 gene, do not form MBs but suffer from extensive porphyria and progressive toxic liver damage, leading to the death of a considerable number of animals (7 of 12 during 12 weeks of intoxication). Our observations show that 1) in the absence of CK8 as well as in the situation of a relative excess of CK18 over CK8 no MBs are formed; 2) the loss of CK8 is not compensated by other type II CKs; and 3) porphyria and toxic liver damage are drastically enhanced in the absence of CK8. Our results point to a protective role of CKs in certain types of toxic liver injury and suggest that MBs by themselves are not harmful to hepatocytes but may be considered as a product of a novel defense mechanism in hepatocytes.
authors.affiliation: Department of Pathology, University of Graz, Graz, Austria. kurt.zatloukal@kfunigraz.ac.at
authors.forename: K
authors.initials: K
authors.lastname: Zatloukal
authors.forename: C
authors.initials: C
authors.lastname: Stumptner
authors.forename: M
authors.initials: M
authors.lastname: Lehner
authors.forename: H
authors.initials: H
authors.lastname: Denk
authors.forename: H
authors.initials: H
authors.lastname: Baribault
authors.forename: L G
authors.initials: LG
authors.lastname: Eshkind
authors.forename: W W
authors.initials: WW
authors.lastname: Franke
mesh_terms: D000818:Animals; D001652:Bile Ducts / Q000502:physiology; D056486:Chemical and Drug Induced Liver Injury; D003593:Cytoplasm / Q000502:physiology* / Q000648:ultrastructure; D003599:Cytoskeleton / Q000648:ultrastructure; D003997:Dicarbethoxydihydrocollidine; D004848:Epithelium / Q000502:physiology; D053552:Keratin-7; D007633:Keratins / Q000235:genetics / Q000378:metabolism* / Q000502:physiology*; D008099:Liver / Q000166:cytology / Q000473:pathology / Q000502:physiology*; D008107:Liver Diseases / Q000473:pathology / Q000517:prevention & control*; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout / Q000235:genetics
chemical_list: D053552:Keratin-7; C507496:Krt7 protein, mouse; D003997:Dicarbethoxydihydrocollidine; D007633:Keratins